This morning Fitbit landed FDA clearance for its long-awaited photoplethysmography atrial fibrillation (AFib) detection algorithm. The algorithm will be part of Fitbit's new Irregular Heart Rhythm ...

The US Food and Drug Administration has approved Google's Fitbit photoplethysmography (PPG) algorithm to identify atrial fibrillation (AFib). Google says the AFib detection feature will be coming soon ...

Just a few months after Fitbit roped in FDA clearance for an algorithm that could be embedded into its eponymous health-tracking wearables to detect atrial fibrillation, the technology is ready to hit ...

In 2018, Apple irrevocably blurred the line between consumer technology and medical devices as it landed FDA approval for a pair of high-tech features. One allows the Apple Watch to perform ...

Add Yahoo as a preferred source to see more of our stories on Google. Two weeks back, Google announced that it was seeking U.S. Food and Drug Administration approval for a new atrial ...

Just a few weeks after announcing its intentions, Fitbit and Google have today announced that clearance has been granted in the United States for select trackers and smartwatches to detect irregular ...

オムロン ヘルスケアは、血圧を測定するだけで不整脈の一種である心房細動の可能性を検出する、血圧計搭載アルゴリズム「Intellisense AFib(インテリセンスエイフィブ)」を開発した。2024年10月に、米国食品薬品局(Food and Drug Administration)の認可を取得。「心房 ...

Two weeks back, Google announced that it was seeking U.S. Food and Drug Administration approval for a new atrial fibrillation-detecting technology it planned to roll out to Fibit wearables. Today, the ...

On Friday, the Food and Drug Administration granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch.

～米国初、心房細動の可能性を検出する血圧計としてFDAのDeNovo認可を取得～ オムロン ヘルスケア株式会社（本社所在地：京都府向日市、代表取締役社長:岡田 歩、以下当社）は、心電図を記録せずに血圧を測定するだけで不整脈の一種である心房細動の可能 ...